Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor effects of Techniclone's LYM-2 reported

Oct. 29, 1997

Research team identifies effector of morphological changes during apoptosis

Oct. 28, 1997

Oxford BioMedica acquires novel anticancer technology

Oct. 28, 1997

Endorex raises funds for clinical testing of antitumor drugs

Oct. 28, 1997

Preclinical studies on FK-317 presented at cancer meeting

Oct. 28, 1997

DAB-720: a new EGF receptor TK inhibitor from Mitsubishi Chemical

Oct. 28, 1997

Mechanism of action and in vivo antitumor efficacy reported for CS-682

Oct. 28, 1997

Novel antiangiogenic agent with oral activity in animal model of breast cancer

Oct. 28, 1997

SuperGen files supplemental NDA for Nipent

Oct. 27, 1997

Apoptotic effects described for antiestrogen

Oct. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.